|Student Contribution Band:||Band 2|
|Administered by:||College of Medicine & Dentistry|
Mental health is becoming an increasingly important aspect of daily living, with conditions such as depression, anxiety, schizophrenia, and bipolar disorder affecting a significant proportion of the Australian population. Both neurological and psychiatric conditions require regular communication with health professionals, including pharmacists, to ensure that the treatment plan being enacted is managing the condition(s) effectively. Chronic pain can have a dramatic effect on mental health, with substance abuse disorders such as nicotine, alcohol, and opioid addictions often coinciding with pain and mental health disorders. Similarly chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) represent a significant health burden on the wider community and can have large implications on quality of life. Students in this subject will learn about the pathophysiology of multiple conditions within these fields, and will have a strong understanding of the vast array of medications available for the conditions presented. They will also improve their professional communication skills with both patients and prescribers to ensure the best outcomes from treatment.
|As this is a core level 3 subject in the BPharm(Hons)/MPharm pathway, students will be expected to have completed all core level 1 and 2 subjects.|
|Townsville, Internal, Study Period 2|
|Census Date 26-Aug-2021|
|Coordinator:||Dr John Smithson|
|Lecturers:||Professor Beverley Glass, Dr Martina Mylrea, Mr Shane MacDonald, Dr Robi Islam.|
The student workload for this 6 credit point subject is approximately 260 hours.
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.